KLSE (MYR): FOCUSP (0157)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.825
Today's Change
+0.01 (1.23%)
Day's Change
0.815 - 0.825
Trading Volume
434,000
Market Cap
381 Million
NOSH
462 Million
Latest Quarter
31-Mar-2024 [#1]
Announcement Date
23-May-2024
Next Quarter
30-Jun-2024
Est. Ann. Date
22-Aug-2024
Est. Ann. Due Date
29-Aug-2024
QoQ | YoY
-29.27% | 22.89%
Revenue | NP to SH
269,524.000 | 31,531.000
RPS | P/RPS
58.34 Cent | 1.41
EPS | P/E | EY
6.82 Cent | 12.09 | 8.27%
DPS | DY | Payout %
3.25 Cent | 3.94% | 47.62%
NAPS | P/NAPS
0.27 | 3.04
QoQ | YoY
4.58% | -12.86%
NP Margin | ROE
11.70% | 25.14%
F.Y. | Ann. Date
31-Mar-2024 | 23-May-2024
Latest Audited Result
31-Dec-2023
Announcement Date
10-May-2024
Next Audited Result
31-Dec-2024
Est. Ann. Date
10-May-2025
Est. Ann. Due Date
29-Jun-2025
Revenue | NP to SH
260,897.000 | 30,150.000
RPS | P/RPS
56.47 Cent | 1.46
EPS | P/E | EY
6.53 Cent | 12.64 | 7.91%
DPS | DY | Payout %
3.00 Cent | 3.64% | 45.97%
NAPS | P/NAPS
0.26 | 3.23
YoY
-15.91%
NP Margin | ROE
11.56% | 25.55%
F.Y. | Ann. Date
31-Dec-2023 | 22-Feb-2024
Revenue | NP to SH
273,184.000 | 29,652.000
RPS | P/RPS
59.13 Cent | 1.40
EPS | P/E | EY
6.40 Cent | 12.85 | 7.78%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
-1.65% | 22.89%
NP Margin | ROE
10.85% | 23.64%
F.Y. | Ann. Date
31-Mar-2024 | 23-May-2024
Trailing 4 Quarters | Trailing 8 Quarters | |||
---|---|---|---|---|
Available Quarters | 4 Quarters | 8 Quarters | ||
Continuous Quarters Of Revenue Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Total Positive Profit Years | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
Continuous Quarters Of Positive Profit | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
Continuous Quarters Of Profit Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted EPS Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Total Dividend Years | 2 / 4 | 50.00% | 4 / 8 | 50.00% |
Continuous Quarters Of Dividend | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
Average ROE | 6.77% | 8.07% | ||
Average Net Profit Margin | 11.62% | 12.81% |
Last 5 Financial Years | Last 10 Financial Years | |||
---|---|---|---|---|
Available Years | 5 Years | 10 Years | ||
Continuous Quarters Of Revenue Growth | 3 / 5 | 60.00% | 3 / 10 | 30.00% |
Total Positive Profit Years | 5 / 5 | 100.00% | 8 / 10 | 80.00% |
Continuous Quarters Of Positive Profit | 5 / 5 | 100.00% | 6 / 10 | 60.00% |
Continuous Quarters Of Profit Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
Continuous Quarters Of Adjusted EPS Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
Total Dividend Years | 5 / 5 | 100.00% | 7 / 10 | 70.00% |
Continuous Quarters Of Dividend | 5 / 5 | 100.00% | 6 / 10 | 60.00% |
Continuous Quarters Of Dividend Growth | 3 / 5 | 60.00% | 3 / 10 | 30.00% |
Continuous Quarters Of Adjusted Dps Growth | 3 / 5 | 60.00% | 3 / 10 | 30.00% |
Average ROE | 22.17% | 12.48% | ||
Average Net Profit Margin | 9.21% | 5.04% |
T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
---|---|---|---|---|---|
Revenue | 269,524 | 273,184 | 260,897 | 184,520 | 206,156 |
NP to SH | 31,531 | 29,652 | 30,150 | 10,851 | 20,115 |
Dividend | 15,014 | 32,339 | 13,859 | 4,264 | 7,868 |
Adjusted EPS | 6.82 | 6.40 | 6.53 | 2.35 | 4.35 |
Adjusted DPS | 3.25 | 7.00 | 3.00 | 0.92 | 1.70 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
---|---|---|---|---|---|
Revenue | -7.35% | 14.46% | 14.46% | 1.36% | 3.85% |
NP to Owner | -29.27% | 22.89% | 22.89% | -5.96% | -12.42% |
Dividend | 0.00% | 16.67% | 16.67% | 115.38% | 140.49% |
Adjusted EPS | -29.52% | 22.55% | 22.55% | -6.30% | -12.70% |
Adjusted DPS | 0.00% | 16.67% | 16.67% | 115.38% | 140.49% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 3.31% | 30.74% | 46.07% | 4.71% | 32.51% | 48.05% | 4.85% | 26.55% | 41.39% |
NP to Owner | 4.58% | 56.75% | 190.56% | -1.65% | 47.41% | 173.24% | -15.91% | 49.88% | 177.83% |
Dividend | 8.33% | 90.82% | 252.11% | 133.33% | 311.00% | 658.38% | 40.00% | 76.14% | 225.02% |
Adjusted EPS | 4.44% | 56.61% | 190.30% | -1.99% | 46.96% | 172.42% | -15.86% | 49.95% | 177.95% |
Adjusted DPS | 8.33% | 90.82% | 252.11% | 133.33% | 311.00% | 658.38% | 40.00% | 76.14% | 225.02% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3341863
The Board of Directors of Focus Point Holdings Berhad ("the Company") is pleased to announce that the resolution as set out in the Notice convening of the Extraordinary General Meeting ("EGM") dated 17 March 2023, was duly passed at the EGM of Company held earlier today, 4 April 2023.
PROPOSED BONUS ISSUE OF UP TO 131,999,790 NEW ORDINARY SHARES IN FOCUS POINT ("FOCUS POINT SHARES") ("BONUS SHARES") ON THE BASIS OF 2 BONUS SHARES FOR EVERY 5 EXISTING FOCUS POINT SHARES HELD ON AN ENTITLEMENT DATE TO BE DETERMINED AND ANNOUNCED LATER ("PROPOSED BONUS ISSUE OF SHARES")
2023-04-05 10:29
https://theedgemalaysia.com/node/683365
the research house said that encouragingly, corporate sales chartered a 56% year-on-year (y-o-y) growth on the back of active on-boarding of new customers.
It said the group also continues to drive stronger marketing and promotional activities to push retail sales.
As for F&B (food and beverage), we are confident that the sales momentum will continue with the increase in orders from new corporate clients.
2023-09-21 16:27
Focus point is another consumer stock that retail investors can pay attention to.....still quite low valuation, waiting for HL research to give new TP........ :)
2023-10-03 13:28
very good co, shud buy no need think. Yes FocusP still supply to familymart but starbucks biz affected due to boycott
2024-01-02 22:38
Does anyone can some shed light on why the F&B segment was making a loss? I was not convinced that it was caused by the over staff.
2024-01-03 12:22
any new visits from the IR side?
looking for a good business gained from the contracts
2024-01-08 17:11
Notable substantial shareholders include Malaysia government 13,39%, Hong Leong Asset Management 6.54%, Public Mutual 3.39%, Kenanga Investor Bhd 1.288%, Hong Leong Foundation 1.136%
2024-02-09 15:22
wow QR cantik! tp mcm cash dah guna kat expansion, komugi baru ke ni?
apa yogurt brand dia?
2024-02-22 21:13
Bought first lot. So reasonable or even can say cheap. Good chance for a quick profit
2024-03-06 12:11
Why the share price keep dropping?
8dragon
Will only buy if drop to 0.65...
- Why is 0.65 ya?
2024-03-21 00:17
As of 2024-04-17, the Intrinsic Value of Focus Point Holdings Bhd (FOCUSP.KL) is 1.04 MYR. This FOCUSP.KL valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.71 MYR, the upside of Focus Point Holdings Bhd is 46%.
The range of the Intrinsic Value is 0.77 - 1.54 MYR.
2 months ago
Easy for the company to replicate yogurt shops at the malls competing with lialiao. At least it is healthier for elderly than sugary drinks of so many franchises eg Teal...
2 months ago
I recall reading in the Edge In Dec23/Jan24 that Focusp was some fund manager's stock pick for the year. It's May already... and focusp is still trading between 70-77 sen *yawn*
But trailing PE is 11.5x... attractive for consumer stock, esp since it has own brands. Why not much interest ler??
1 month ago
Another great QR, YoY improved! And we shall see F&B be profitable should they continue this trend next cycle. Seems like the new franchise might be a timely addition too, little to no negative impact I presume.
Meanwhile, the lower QoQ is consistent with the cyclical demand of the FY. I wonder if they will expand their eye-care business in terms of hospitalized / in-out patient care like Optimax do? Anyone today attended the AGM and asked?
1 month ago
Yes, this is the bursa way. Buy on rumor sell on news. Hence, its the early bird gets the worm.
1 month ago
pinnaclegrade
bonus issue is just a marketing gimmick, to appear "cheaper" than it really is
2023-02-22 09:26